BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Poached From AstraZeneca, New Pharma Head Looks to Resuscitate GlaxoSmithKline’s Cancer Pipeline

  GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

  December 11, 2017

   · 

  1 min read
• Deals

  Medtronic Takes Out Crospon in $45M Deal

  Medtronic confirmed that it bought Crospon but declined to disclose the value of the deal.

  December 11, 2017

   · 

  1 min read
• 

  Business

  Intuitive Surgical Pays $274M to Goldman Sach, Closes $2B Share Buyback Deal

  The payback was part of a total $3 billion stock repurchasing deal the company initiated on January 27.

  December 11, 2017

   · 

  1 min read
• Business

  Week in Review: China Life Science Deals Total $550M

  Pfizer acquired China/Asia rights for Cresemba, an antifungal drug developed by Swiss pharma Basilea, in a $226M deal.

  December 11, 2017

   · 

  1 min read
• Deals

  China Investor Syndicate Acquires Esaote, an Italian Imaging Device Company

  Esaote S.p.A., an Italian medical imaging company, has been acquired by a group of China investors.

  December 11, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About Corbin Therapeutics

  Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem.

  December 11, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Merck Laying Off 50 Employees in North Carolina

  Layoffs are expected to begin in February, according to reports.

  December 11, 2017

   · 

  2 min read

   · 

  Alex Keown
• Pharm Country

  OncoTartis Closes $6M Financing Round

  OncoTartis has concluded a $6M financing round to support the Phase 1 clinical trial of its lead drug candidate, OT-82.

  December 11, 2017

   · 

  2 min read
• Business

  Cardiome Highlights Partner SteadyMed’s Agreement With FDA on Pathway to Trevyent NDA Resubmission

  Cardiome plans to submit regulatory filings for Trevyent in Europe and Canada shortly following SteadyMed’s NDA resubmission to the FDA.

  December 11, 2017

   · 

  7 min read
• Drug Development

  Caris Life Sciences Identifies New Mechanism of Action for an Aptamer With Therapeutic Potential to Treat Non-Hodgkin Lymphoma

  Results of this study showed that C10.36 binding to cell-surface hnRNP U resulted in internalization of the complex, disruption of pre-mRNA splicing and cell death in a subset of NHL cell lines in vitro.

  December 11, 2017

   · 

  3 min read